30 Participants Needed

Safety Planning for Suicide Prevention

(HSI Trial)

JA
ST
SS
Overseen ByShalomi Shelton
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the treatment Enhanced Lethal Means Safety Plan for suicide prevention?

Research shows that safety planning, which includes removing dangerous means for suicide, is highly effective in lowering suicidal behavior. This approach is used in various settings and has shown promising results in reducing suicide risk, especially when combined with other supportive strategies.12345

Is the Enhanced Lethal Means Safety Plan safe for humans?

The Enhanced Lethal Means Safety Plan, which involves counseling to reduce access to firearms and medications, is generally considered safe as it focuses on making the environment safer for individuals at risk of suicide. It is a recommended strategy in emergency settings and involves voluntary changes in behavior.16789

How is the Enhanced Lethal Means Safety Plan treatment different from other suicide prevention treatments?

The Enhanced Lethal Means Safety Plan is unique because it focuses on reducing access to means of self-harm, which is a proven strategy at the population level, but less understood on an individual level. Unlike traditional treatments, it emphasizes creating a personalized plan to limit access to lethal means, which can be more effective in preventing impulsive suicidal actions.68101112

What is the purpose of this trial?

Access to lethal methods of self-harm such as firearms and medications increases risk for suicide. As such, VA/DoD guidelines for the care of individuals with elevated suicide risk include recommendations that clinicians deliver interventions to reduce access to lethal methods of suicide among patients who are identified as having elevated suicide risk. However, no interventions have been developed or tested among Veterans with elevated suicide risk. The aim of this study is to pilot test a lethal means safety intervention developed specifically for Veterans who seek care in VHA clinical settings and are identified as having elevated suicide risk.

Research Team

JA

Joseph A Simonetti, MD MPH

Principal Investigator

Rocky Mountain Regional VA Medical Center, Aurora, CO

Eligibility Criteria

This trial is for Veterans over 17 years old who visited a VHA emergency department or urgent care, are at intermediate to high suicide risk, and have access to firearms or medications. They must be discharged home, willing to review a safety plan, and able to consent. Those with severe illness, intoxication issues, unreliable phone access, homelessness without an address, or daily substance abuse can't join.

Inclusion Criteria

Patient-reported access to firearms and/or medications
I was sent home after my emergency department visit.
Suicide risk is determined to be intermediate or high based on the CSRE results
See 3 more

Exclusion Criteria

I am able to understand and consent to my own medical treatment.
Unreliable telephone access
Those currently experiencing unsheltered homelessness
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the lethal means safety intervention developed specifically for Veterans with elevated suicide risk

1 day
1 visit (in-person)

Follow-up

Participants are monitored for changes in firearm and medication storage practices and beliefs about safety measures

4 weeks
2 optional visits (in-person)

Extended Follow-up

Verification of naloxone prescription and medication return envelope

8 weeks

Treatment Details

Interventions

  • Enhanced Lethal Means Safety Plan
Trial Overview The study tests an enhanced lethal means Safety Plan intervention designed for Veterans identified as having elevated suicide risk in emergency settings. It aims to reduce the risk of suicide by limiting access to methods like firearms and medications.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: intervention armExperimental Treatment1 Intervention
There is a single intervention arm with no comparator for this pilot study

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Findings from Research

The 'Lock to Live' decision aid for lethal means safety shows promise in helping emergency department clinicians counsel patients at risk of suicide, based on qualitative interviews with 15 clinicians.
Successful implementation of the tool depends on clinicians' perceptions of its utility, time constraints, and how well it fits into the existing emergency department workflow.
Lethal means counseling for suicide prevention: Views of emergency department clinicians.Siry, BJ., Polzer, E., Omeragic, F., et al.[2022]
The implementation of a treatment escalation/limitation plan (TELP) alongside a do-not-attempt cardiopulmonary resuscitation order (DNACPR) significantly reduced the rates of harms, non-beneficial interventions, and clinical problems in patients who died in the hospital, compared to those with DNACPR only or neither plan.
In a study of 289 patients, those with a TELP/DNACPR experienced much lower incidences of adverse outcomes, with harms occurring at a rate of 17.1 per 1000 bed days compared to 76.9 for DNACPR only and 197.8 for those with neither, highlighting the effectiveness of TELP in managing end-of-life care.
Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method.Lightbody, CJ., Campbell, JN., Herbison, GP., et al.[2023]
The Safety Planning Intervention (SPI) is a structured six-step action plan designed to help individuals at risk of suicide by enhancing their coping strategies and social support, and by removing access to means of self-harm.
Research shows that SPI is highly effective in reducing suicidal behavior, making it a valuable tool in various settings such as emergency rooms and outpatient clinics.
[SAFETY PLANNING INTERVENTION FOR SUICIDE PREVENTION].Perlstein, J., Katzir, N., Lotan, A., et al.[2022]

References

Lethal means counseling for suicide prevention: Views of emergency department clinicians. [2022]
Impact of a treatment escalation/limitation plan on non-beneficial interventions and harms in patients during their last admission before in-hospital death, using the Structured Judgment Review Method. [2023]
[SAFETY PLANNING INTERVENTION FOR SUICIDE PREVENTION]. [2022]
Crisis service utilization following completion of a suicide safety plan for Veterans with and without affective and nonaffective psychosis. [2023]
Safety Planning: Why It Is Essential on the Day of Discharge From In-patient Psychiatric Hospitalization in Reducing Future Risks of Suicide. [2023]
Lethal Means Assessment in Psychiatric Emergency Services: Frequency and Characteristics of Assessment. [2022]
Therapeutic Risk Management and Firearm-related Lethal Means Safety. [2023]
Predictive Importance of Social Contacts on U.S. Veteran Suicide Safety Plans. [2023]
Stakeholder perceptions of lethal means safety counseling: A qualitative systematic review. [2023]
MYPLAN - A Mobile Phone Application for Supporting People at Risk of Suicide. [2022]
Teaching health care professionals about suicide safety planning. [2022]
The Effectiveness of the Safety Planning Intervention for Adults Experiencing Suicide-Related Distress: A Systematic Review. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity